insights_auto
Why is GH up 2,50%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
166,66 USD
arrow_upward
+2,50%(+4,07) 1D
166,66 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 21-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
162,29 USD
High
171,22 USD
Low
162,00 USD
Mkt. cap
22,37 млд
Avg. vol.
1,78 млн
Volume
2,54 млн
52-wk high
191,01 USD
52-wk low
66,59 USD
EPS
-3,50 USD
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 миң
Open
162,29 USD
High
171,22 USD
Low
162,00 USD
Mkt. cap
22,37 млд
Avg. vol.
1,78 млн
Volume
2,54 млн
52-wk high
191,01 USD
52-wk low
66,59 USD
EPS
-3,50 USD
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 миң
News stories
From web sources and news partners
News Corp
·
4 саат мурун
7 healthcare stocks that stand out as investors pay up for the sector
Zacks
·
11 саат мурун
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Stock Titan
·
1 күн мурун
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
Stocks Down Under
·
2 күн мурун
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 миң
Founded2012
HeadquartersПало Альто, Калифорния, Америка Кошмо Штаттары
SectorHealth care provider
Websiteguardanthealth.com